Mounjaro dethrones Keytruda and GLP-1s may help cancer patients live longer.
May 13, 2026

1. GLP-1s linked to higher breast cancer survival: 3 notes Full story

2. Mounjaro surpasses Keytruda as top-selling drug Full story

3. Revenue leakage starts before the first claim is filed. Where AI agents are closing the gap: here.

 

4. 'US has gone into a peptide craziness': Wegovy pill nets 2 million scripts since launch Full story

5. Pancreatic cancer drug extends survival 8.5 months: Study Full story

6. Critical incident response: See what healthcare workers need in the first 24 hours here.

 

7. The strategy questions oral GLP-1s pose for pharmacy leaders Full story

8. 7 new drugs in shortage Full story

Becker's Learning Opportunities

9. Jefferson Health, Memorial Hermann and Arkansas Children's are escaping reactive operations — see how here.

10. 70+ system leaders reveal their biggest operational challenges — and the strategies gaining traction here.

11. Radiology's AI moment has arrived. Leaders from St. Jude Children's share why here.

12. Becker’s resources don’t stop here — explore more webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 
 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication